Geron

IPO

Public · Foster City, United States · Founded 1990

Employees
201–500
Founded
1990
Business Model
B2G
Website
geron.com
Type
Public

About

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Summary

Geron is a Biotech company based in Foster City, United States, founded in 1990. Investors include Pharmakon Advisors.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Debt FinancingDebt FinancingNov 2024
$250.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies